Prof. Dr. İLKAY YILDIZ

Yayın Ağı

Makaleler 114

1. Some Benzoxazole Derivatives as Potential mTOR Inhibitors: Anticancer Activity and Molecular Docking Studies in Breast Cancer

Köprü Ç. Z., Baba B., Ahmet Naji S., Yıldız İ., Akbay A.

Uludağ Üniversitesi Tıp Fakültesi Dergisi , cilt.51, ss.443-450, 2025 (TRDizin)

2. Computational assessment of the reactivity and anticancer activity of 1,2,3-triazole-thiazolidinones derivatives: An approach combining DFT calculations, molecular dynamics simulations, molecular docking, and ADMET

Bimoussa A., Hachim M. E., Laamari Y., Geesi M. H., MUHAMMED M. T., Alamri M. A., et al.

JOURNAL OF MOLECULAR STRUCTURE , cilt.1321, 2025 (SCI-Expanded) Sürdürülebilir Kalkınma

3. Furopyridine Derivatives as Potent Inhibitors of the Wild Type, L858R/T790M, and L858R/T790M/C797S EGFR

Todsaporn D., Zubenko A., Kartsev V. G., Mahalapbutr P., Geronikaki A., Sirakanyan S. N., et al.

Journal of Physical Chemistry B , cilt.128, sa.50, ss.12389-12402, 2024 (SCI-Expanded)

4. A novel D-limonene derivative: synthesis, characterization, molecular docking, molecular dynamics and ADMET prediction studies

Fawzi M., Laamari Y., Oubella A., Rehman M. T., Sahin E., Fahad AlAjmi M., et al.

Journal of Sulfur Chemistry , cilt.45, sa.6, ss.831-849, 2024 (SCI-Expanded)

5. Discovery of Novel EGFR Inhibitor Targeting Wild-Type and Mutant Forms of EGFR: In Silico and In Vitro Study

Todsaporn D., Zubenko A., Kartsev V., Aiebchun T., Mahalapbutr P., Petrou A., et al.

MOLECULES , cilt.28, ss.1-20, 2023 (SCI-Expanded)

6. In silico investigation of the interactions of certain drugs proposed for the treatment of Covid-19 with the paraoxonase-1

Duzgun Z., Kural B. V., Örem A., Yıldız İ.

Journal of Biomolecular Structure and Dynamics , cilt.41, sa.3, ss.884-896, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

7. Antitumor activity against human promyelocytic leukemia and in silico studies of some benzoxazines

ÖKSÜZOĞLU E., YILMAZ S., YENİCE ÇAKMAK G., Ataei S., YILDIZ İ.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS , cilt.41, sa.17, ss.8175-8190, 2023 (SCI-Expanded, Scopus)

8. Design, synthesis, and computational studies of benzimidazole derivatives as new antitubercular agents

Yalcin-Ozkat G., Ersan R. H., ÜLGER M., TEZCAN ÜLGER S., BURMAOĞLU S., YILDIZ İ., et al.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS , cilt.41, sa.7, ss.2667-2686, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

9. Biological activity and ADME/Tox prediction of some 2-substituted benzoxazole derivatives

Foto F. Z., FOTO E., ERTAN BOLELLİ T., YILDIZ İ.

BIOORGANIC CHEMISTRY , cilt.123, 2022 (SCI-Expanded, Scopus)

10. QSAR based on hybrid optimal descriptors as a tool to predict antibacterial activity against Staphylococcus aureus

Nesmerak K., Toropov A., YILDIZ İ.

FRONTIERS IN BIOSCIENCE-LANDMARK , cilt.27, sa.4, 2022 (SCI-Expanded)

11. In Silico Studies to Develop New GSK3 beta Inhibitors Effective in the 's Disease

Ozkat G. Y., YILDIZ İ.

LETTERS IN DRUG DESIGN & DISCOVERY , cilt.19, sa.8, ss.691-705, 2022 (SCI-Expanded, Scopus)

12. Quantum Mechanical Studies of Three Aromatic Halogen-Substituted Bioactive Sulfonamidobenzoxazole Compounds with Potential Light Harvesting Properties

Mary Y. S., ERTAN BOLELLİ T., Thomas R., Krishnan A. R., BOLELLİ K., Kasap E. N., et al.

POLYCYCLIC AROMATIC COMPOUNDS , cilt.41, sa.7, ss.1563-1579, 2021 (SCI-Expanded, Scopus)

13. Discovery of 5-(or 6)-benzoxazoles and oxazolo[4,5-b]pyridines as novel candidate antitumor agents targeting hTopo II alpha

Karatas E., FOTO E., ERTAN BOLELLİ T., Yalcin-Ozkat G., YILMAZ S., Ataei S., et al.

BIOORGANIC CHEMISTRY , cilt.112, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. Artificial intelligence on drug discovery and development İlaç keşfİ ve gelİştİrİlmesİnde yapay zekâ

Çelik İ. N., Arslan F. K., Tunç R., YILDIZ İ.

Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.45, sa.2, ss.400-427, 2021 (Scopus)

15. Benzoxazines as new human topoisomerase I inhibitors and potential poisons

FOTO E., Ozen C., Zilifdar F., Tekiner-Gulbas B., YILDIZ İ., Aki-Yalcin E., et al.

DARU-JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.28, sa.1, ss.65-73, 2020 (SCI-Expanded, Scopus)

16. Spectroscopic, quantum mechanical studies, ligand protein interactions and photovoltaic efficiency modeling of some bioactive benzothiazolinone acetamide analogs

Mary Y. S., YALÇIN ÖZKAT G., Mary Y. S., Resmi K. S., Thomas R., Onkol T., et al.

CHEMICAL PAPERS , cilt.74, sa.6, ss.1957-1964, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

17. Synthesis and molecular docking studies of some novel antimicrobial benzamides

Acar C., YALÇIN ÖZKAT G., ERTAN BOLELLİ T., KAYNAK ONURDAĞ F., ÖKTEN S., Sener F., et al.

BIOORGANIC CHEMISTRY , cilt.94, 2020 (SCI-Expanded, Scopus)

18. Molecular docking studies on some benzamide derivatives as topoisomerase inhibitors Topoizomeraz inhibitörleri olarak bazi benzamid türevleri üzerinde moleküler doking cąlismalari

Yilmaz S., Ataei S., YILDIZ İ.

Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.44, sa.3, ss.470-480, 2020 (Scopus)

19. Topoisomerase II enzyme inhibitors TOPOIZOMERAZ II ENZIM INHIBITÖRLERI

Firat O., YILDIZ İ.

Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.44, sa.2, ss.356-372, 2020 (Scopus)

20. Comparison of partition coefficient (log P) prediction softwares Partisyon katsayisi (Log P) Tahmininde Kullanilan Yazilimlarin karşilaştirilmasi

KIŞLA M. M., YILDIZ İ.

Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.43, sa.1, ss.1-19, 2019 (Scopus)

21. HPLC-MS analysis of ipecacuanha alkaloids in pharmaceutical relics from eighteenth century

Nesmerak K., Kudlacek K., Sticha M., Cerveny V., Kunesova J., YILDIZ İ.

MONATSHEFTE FUR CHEMIE , cilt.149, sa.9, ss.1535-1542, 2018 (SCI-Expanded, Scopus)

22. Molecular docking studies on fluoro-substituted chalcones as potential DprE1 enzyme inhibitors

YALÇIN ÖZKAT G., BURMAOĞLU S., YILDIZ İ., ALGÜL Ö.

JOURNAL OF MOLECULAR STRUCTURE , cilt.1164, ss.50-56, 2018 (SCI-Expanded, Scopus)

23. Pharmacophore generation studies for the discovery of potential glycogen synthase kinase 3 beta enzyme inhibitors

YALÇIN ÖZKAT G., YILDIZ İ.

FEBS OPEN BIO , cilt.8, ss.447, 2018 (SCI-Expanded)

24. Molecular binding profile of protoberberine alkaloids on glycogen synthase kinase 3β as a drug candidate for alzheimer’s diseases Alzheimer hastaliğinda ilaç adayi olarak protoberberin alkaloitlerinin glikojen sentaz kinaz 3β ile moleküler bağlanma profilleri

Yalcin G., YILDIZ İ.

Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.42, sa.3, ss.1-12, 2018 (Scopus)

25. Design and synthesis of 2-substituted-5-(4-trifluoromethylphenyl-sulphonamido)benzoxazole derivatives as human GST P1-1 inhibitors

ERTAN BOLELLİ T., BOLELLİ K., MUŞDAL Y., YILDIZ İ., Aki-Yalcin E., Mannervik B., et al.

ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY , cilt.46, sa.3, ss.510-517, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

26. Inhibition of DNA Topoisomerases by a Series of Benzoxazoles and their Possible Metabolites

Zilifdar F., Foto E., ERTAN BOLELLİ T., YILDIZ İ., Aki-Yalcin E., DİRİL N.

LETTERS IN DRUG DESIGN & DISCOVERY , cilt.15, sa.11, ss.1155-1162, 2018 (SCI-Expanded, Scopus)

27. QSAR of antimycobacterial activity of benzoxazoles by optimal SMILES-based descriptors

Nesmerak K., Toropov A. A., Toropova A. P., ERTAN BOLELLİ T., YILDIZ İ.

MEDICINAL CHEMISTRY RESEARCH , cilt.26, sa.12, ss.3203-3208, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

28. Modification of benzoxazole derivative by bromine-spectroscopic, antibacterial and reactivity study using experimental and theoretical procedures

Aswathy V. V., Alper-Hayta S., YALÇIN ÖZKAT G., Mary Y. S., Panicker C. Y., Jojo P. J., et al.

JOURNAL OF MOLECULAR STRUCTURE , cilt.1141, ss.495-511, 2017 (SCI-Expanded, Scopus)

29. Vibrational spectroscopic analysis, molecular dynamics simulations and molecular docking study of 5-nitro-2-phenoxymethyl benzimidazole

Menon V. V., Foto E., Mary Y. S., Karatas E., Panicker C. Y., YALÇIN ÖZKAT G., et al.

JOURNAL OF MOLECULAR STRUCTURE , cilt.1129, ss.86-97, 2017 (SCI-Expanded, Scopus)

30. Antitumor activities on HL-60 human leukemia cell line, molecular docking, and quantum-chemical calculations of some sulfonamide-benzoxazoles

ÖKSÜZOĞLU E., ERTAN BOLELLİ T., CAN H., Tarhan M., ÖZTÜRK K., YILDIZ İ.

ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY , cilt.45, sa.7, ss.1388-1396, 2017 (SCI-Expanded, Scopus)

31. GENOTOXIC PROPERTIES OF SOME N-PHENYLBENZAMIDE AND N-PHENYLACETAMIDE DERIVATIVES

ZİLİFDAR F., FOTO E., ERTAN BOLELLİ T., AKI YALÇIN E. E., YALÇIN İ., YILDIZ İ.

The Turkish Journal Of Occupational / Environmental Medicine and Safety , cilt.2, sa.1(1), ss.305, 2017 (Hakemli Dergi)

32. Docking Studies on Enoyl Acyl Carrier Protein ACP Reductase Enzyme Inhibitors

Şenel U., ERTAN BOLELLİ T., BOLELLİ K., YILDIZ İ.

Ankara Üniversitesi Eczacılık Fakültesi Dergisi , cilt.40, sa.1, ss.25-35, 2016 (Scopus)

33. Molecular modeling studies on DNA topoisomerase I inhibitors

YILDIZ İ., Ataei S., Karataş E., Foto E., DİRİL N.

Journal of Pharmaceutics & Drug Delivery Research , cilt.5, sa.05, ss.47, 2016 (Hakemli Dergi)

34. Synthesis, molecular docking and antimicrobial evaluation of novel benzoxazole derivatives

ERTAN BOLELLİ T., YILDIZ İ., Ozgen-Ozgacar S.

MEDICINAL CHEMISTRY RESEARCH , cilt.25, sa.4, ss.553-567, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

35. Enoil-açil taşıyıcı protein (ACP) redüktaz enzim inhibitörleri üzerinde yapılan doking çalışmaları

Şenel U., ERTAN BOLELLİ T., BOLELLİ K., YILDIZ İ.

Ankara Üniversitesi Eczacılık Fakültesi Dergisi , cilt.40, sa.1, ss.25-35, 2016 (Scopus)

36. Docking studies on enoyl-acyl carrier protein (acp) reductase enzyme inhibitors Enoil-açil taşiyici protein (acp) redüktaz enzim Inhibitörleri üzerinde yapilan doking çalişmalari

Şenel U., ERTAN BOLELLİ T., BOLELLİ K., YILDIZ İ.

Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.40, sa.1, ss.25-35, 2016 (Scopus) Sürdürülebilir Kalkınma

37. DFT Study of 3 2 4 chloro phenyl 2 oxo ethyl 5 2 4 dichloro thiazole 5 yl methylenyl thiazolidine 2 4 dione as antifungal agent

YILDIZ İ., DÜNDAR O.

International Journal of Scientific & Engineering Research , 2016 (Hakemli Dergi)

38. Prediction of retention characteristics of heterocyclic compounds

Nesmerak K., Toropov A. A., Toropova A. P., YILDIZ İ., Yalcin I., Brozikova M., et al.

ANALYTICAL AND BIOANALYTICAL CHEMISTRY , cilt.407, sa.30, ss.9185-9189, 2015 (SCI-Expanded, Scopus)

39. Generated 3D-Common Feature Hypotheses Using the HipHop Method For Developing New Topoisomerase I Inhibitors

Ataei S., Yilmaz S., ERTAN BOLELLİ T., YILDIZ İ.

ARCHIV DER PHARMAZIE , cilt.348, sa.7, ss.498-507, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

40. Synthesis and Biological Evaluation of 2-Substituted-5-( 4nitrophenylsulfonamido) benzoxazoles as Human GST P11 Inhibitors, and Description of the Binding Site Features

ERTAN BOLELLİ T., MUŞDAL Y., BOLELLİ K., Yilmaz S., Aksoy Y., YILDIZ İ., et al.

CHEMMEDCHEM , cilt.9, sa.5, ss.984-992, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

41. Quantum mechanical and spectroscopic (FT-IR, FT-Raman, H-1 NMR and UV) investigations of 2-(phenoxymethyl)benzimidazole

Mary Y. S., Jojo P. J., Panicker C. Y., Van Alsenoy C., Ataei S., YILDIZ İ.

SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY , cilt.125, ss.12-24, 2014 (SCI-Expanded, Scopus)

42. Quantum mechanical and spectroscopic (FT-IR, FT-Raman, H-1 NMR and UV) investigations of 5-nitro-2-phenylbenzoxazole

Bhagyasree J. B., Varghese H. T., Panicker C. Y., Samuel J., Van Alsenoy C., ERTAN BOLELLİ T., et al.

JOURNAL OF MOLECULAR STRUCTURE , cilt.1063, ss.16-29, 2014 (SCI-Expanded, Scopus)

43. Theoretical investigations on the molecular structure, vibrational spectra, HOMO-LUMO and NBO analysis of 5-chloro-2-((4-chlorophenoxy)methyl)benzimidazole

Mary Y. S., Jojo P. J., Panicker C. Y., Van Alsenoy C., Ataei S., YILDIZ İ.

SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY , cilt.122, ss.499-511, 2014 (SCI-Expanded, Scopus)

44. Genotoxic potentials and eukaryotic DNA topoisomerase I inhibitory effects of some benzoxazine derivatives

Zilifdar F., Alper-Hayta S., Yilmaz S., Kaplan-Ozen C., Foto E., Aydogan Z., et al.

MEDICINAL CHEMISTRY RESEARCH , cilt.23, sa.1, ss.480-486, 2014 (SCI-Expanded, Scopus)

45. Pharmacophore generation of 2-substituted benzothiazoles as AdeABC efflux pump inhibitors in A. baumannii

Yilmaz S., Altinkanat-Gelmez G., BOLELLİ K., Guneser-Merdan D., Over-Hasdemir M. U., YILDIZ İ., et al.

SAR AND QSAR IN ENVIRONMENTAL RESEARCH , cilt.25, sa.7, ss.551-563, 2014 (SCI-Expanded, Scopus)

46. Evaluation of inhibitory effects of benzothiazole and 3-aminobenzothiazolium derivatives on DNA topoisomerase II by molecular modeling studies

Aki-Yalcin E., ERTAN BOLELLİ T., Taskin-Tok T., Ozturk O., Ataei S., Ozen C., et al.

SAR AND QSAR IN ENVIRONMENTAL RESEARCH , cilt.25, sa.8, ss.637-649, 2014 (SCI-Expanded, Scopus)

47. Benzothiazole derivatives as human DNA topoisomerase II alpha inhibitors

Kaplan-Ozen C., Tekiner-Gulbas B., Foto E., YILDIZ İ., DİRİL N., Aki E., et al.

MEDICINAL CHEMISTRY RESEARCH , cilt.22, sa.12, ss.5798-5808, 2013 (SCI-Expanded, Scopus)

48. Quantum mechanical and spectroscopic (FT-IR, FT-Raman, H-1 NMR and UV) investigations of 2-(p-nitrobenzyl) benzoxazole

Bhagyasree J. B., Varghese H. T., Panicker C. Y., Samuel J., Van Alsenoy C., Yilmaz S., et al.

JOURNAL OF MOLECULAR STRUCTURE , cilt.1046, ss.92-100, 2013 (SCI-Expanded, Scopus)

49. Synthesis and In vitro Antimicrobial Activity of Novel 2-(4-(Substituted-carboxamido)benzyl/phenyl)benzothiazoles

Yilmaz S., Yalcin I., Kaynak-Onurdag F., Ozgen S., YILDIZ İ., Aki E.

CROATICA CHEMICA ACTA , cilt.86, sa.2, ss.223-231, 2013 (SCI-Expanded, Scopus)

50. The determination of toxicities of sulphonylurea and phenylurea herbicides with quantitative structure-toxicity relationship (QSTR) studies

Can A., YILDIZ İ., Guvendik G.

ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY , cilt.35, sa.3, ss.369-379, 2013 (SCI-Expanded, Scopus)

51. Vibrational spectroscopic (FT-IR, FT-Raman, H-1 NMR and UV) investigations and computational study of 5-nitro-2-(4-nitrobenzyl) benzoxazole

Bhagyasree J. B., Varghese H. T., Panicker C. Y., Samuel J., Van Alsenoy C., BOLELLİ K., et al.

SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY , cilt.102, ss.99-113, 2013 (SCI-Expanded, Scopus)

52. Synthesis of novel 2-[4-(4-substitutedbenzamido/phenylacetamido)phenyl]benzothiazoles as antimicrobial agents

BOLELLİ K., Yalcin I., ERTAN BOLELLİ T., Ozgen S., Kaynak-Onurdag F., YILDIZ İ., et al.

MEDICINAL CHEMISTRY RESEARCH , cilt.21, sa.11, ss.3818-3825, 2012 (SCI-Expanded, Scopus)

53. FT-IR, FT-Raman, SERS and computational study of 5-ethylsulphonyl-2-(o-chlorobenzyl)benzoxazole

Mary Y. S., Raju K., YILDIZ İ., ARPACI Ö., Nogueira H. I. S., Granadeiro C. M., et al.

SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY , cilt.96, ss.617-625, 2012 (SCI-Expanded, Scopus)

54. FT-IR, FT-Raman, surface enhanced Raman scattering and computational study of 2-(p-fluorobenzyl)-6-nitrobenzoxazole

Mary Y. S., Raju K., ERTAN BOLELLİ T., YILDIZ İ., Nogueira H. I. S., Granadeiro C. M., et al.

JOURNAL OF MOLECULAR STRUCTURE , cilt.1012, ss.22-30, 2012 (SCI-Expanded, Scopus)

55. Insight into eukaryotic topoisomerase II-inhibiting fused heterocyclic compounds in human cancer cell lines by molecular docking

Taskin T., Yilmaz S., YILDIZ İ., Yalcin I., Aki E.

SAR AND QSAR IN ENVIRONMENTAL RESEARCH , cilt.23, sa.3-4, ss.345-355, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

56. High performance liquid chromotographic method for determination of azithromycin in Lyophilized form

Karban Ö., YILDIZ İ., Ataei S., Karabulut M., DİNÇ E., Tahiyeu R., et al.

Journal of ANALYTICAL AND BIOANALYTICAL Techniques , cilt.3, sa.7, ss.93, 2012 (Hakemli Dergi)

57. Vibrational spectroscopic studies and computational study of 4-fluoro-N-(2 '-hydroxy-4 '-nitrophenyl)phenylacetamide

Mary Y. S., Panicker C. Y., Varghese H. T., Raju K., ERTAN BOLELLİ T., YILDIZ İ., et al.

JOURNAL OF MOLECULAR STRUCTURE , cilt.994, sa.1-3, ss.223-231, 2011 (SCI-Expanded, Scopus)

58. Three-dimensional common-feature hypotheses for hypoglycemic flavonyl-2,4-thiazolidinedione derivatives

YILDIZ İ., BOZDAĞ DÜNDAR O.

MEDICINAL CHEMISTRY RESEARCH , cilt.19, sa.3, ss.211-219, 2010 (SCI-Expanded, Scopus)

59. FT-IR, FT-Raman, SERS spectra and computational calculations of 4-ethyl-N-(2 '-hydroxy-5 '-nitrophenyl)benzamide

Panicker C. Y., Varghese H. T., Ushakumari L., Ertan T., YILDIZ İ., Granadeiro C. M., et al.

JOURNAL OF RAMAN SPECTROSCOPY , cilt.41, sa.4, ss.381-390, 2010 (SCI-Expanded, Scopus)

60. DNA-TOPOISOMERASE INHIBITORY ACTIVITY OF SOME HETEROCYCLIC COMPOUNDS AND THEIR STRUCTURE-ACTIVITY RELATIONSHIPS

Aki E., Yalcin I., YILDIZ İ., Temiz-Arpaci Ö., BOLELLİ K., ERTAN BOLELLİ T.

MEDICINAL CHEMISTRY RESEARCH , cilt.19, 2010 (SCI-Expanded)

61. ANTIMICROBIAL ACTIVITY AND STRUCTURE-ACTIVITY RELATIONSHIPS OF SOME SYNTHESIZED BENZAZOLES AND THEIR POSSIBLE METABOLITES

Yalcin I., Aki E., YILDIZ İ., Temiz-Arpaci Ö.

MEDICINAL CHEMISTRY RESEARCH , cilt.19, 2010 (SCI-Expanded)

62. IR, Raman and SERS spectra of 2-phenoxymethylbenzothiazole

Panicker C. Y., Varghese H. T., Raj A., Raju K., ERTAN BOLELLİ T., YILDIZ İ., et al.

SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY , cilt.74, sa.1, ss.132-139, 2009 (SCI-Expanded, Scopus)

63. Synthesis, biological evaluation and 2D-QSAR analysis of benzoxazoles as antimicrobial agents

Ertan T., YILDIZ İ., Tekiner-Gulbas B., BOLELLİ K., ARPACI Ö., Ozkan S., et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , cilt.44, sa.2, ss.501-510, 2009 (SCI-Expanded, Scopus)

64. Vibrational spectroscopic studies and DFT calculations of 4-fluoro-N-(2-hydroxy-4-nitrophenyl)benzamide

Ushakumari L., Varghese H. T., Panicker C. Y., Ertan T., Yidiz İ.

Journal of Raman Spectroscopy , cilt.39, sa.12, ss.1832-1839, 2008 (SCI-Expanded, Scopus)

65. Synthesis, antimicrobial activity, pharmacophore analysis of some new 2-(substitutedphenyl/benzyl)-5-[(2-benzofuryl)carboxamido]benzoxazoles

Alper-Hayta S., Arisoy M., ARPACI Ö., YILDIZ İ., Aki E., Ozkan S., et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , cilt.43, sa.11, ss.2568-2578, 2008 (SCI-Expanded, Scopus)

66. Vibrational spectroscopic studies and ab initio calculations of 5-nitro-2-(p-fluorophenyl)benzoxazole

Mary Y. S., Varghese H. T., Panicker C. Y., Ertan T., YILDIZ İ., ARPACI Ö.

SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY , cilt.71, sa.2, ss.566-571, 2008 (SCI-Expanded, Scopus)

67. Quantum chemical calculations of warfarin sodium, warfarin and its metabolites

Tekin E. D. (., Erkoc F., YILDIZ İ., Erkoc S.

COMMUNICATIONS IN COMPUTATIONAL PHYSICS , cilt.4, sa.1, ss.161-176, 2008 (SCI-Expanded, Scopus)

68. Synthesis and biological activity of some new benzoxazoles

ARPACI Ö., YILDIZ İ., Oezkan S., Kaynak F., Aki-Sener E., Yalcin I.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , cilt.43, sa.7, ss.1423-1431, 2008 (SCI-Expanded, Scopus)

69. Vibrational spectroscopic studies and ab initio calculations of 5-methyl-2-(p-methylaminophenyl)benzoxazole

Ambujakshan K. R., Madhavan V. S., Varghese H. T., Panicker C. Y., ARPACI Ö., Tekiner-Gulbas B., et al.

SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY , cilt.69, sa.3, ss.782-788, 2008 (SCI-Expanded, Scopus)

70. QSAR and pharmacophore analysis on amides against drug-resistant S. aureus

YILDIZ İ., Ertan T., BOLELLİ K., ARPACI Ö., Yalcin I., Aki E.

SAR AND QSAR IN ENVIRONMENTAL RESEARCH , cilt.19, sa.1-2, ss.101-113, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

71. Some benzoxazoles and benzimidazoles as DNA topoisomerase I and II inhibitors

Oksuzoglu E., Tekiner-Gulbas B., Alper S., ARPACI Ö., Ertan T., YILDIZ İ., et al.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY , cilt.23, sa.1, ss.37-42, 2008 (SCI-Expanded, Scopus)

72. Synthesis, antimicrobial activity and QSAR studies of 2,5-disubstituted benzoxazoles

Arisoy M., ARPACI Ö., YILDIZ İ., Kaynak-Onurdag F., Aki E., Yalcin I., et al.

SAR AND QSAR IN ENVIRONMENTAL RESEARCH , cilt.19, sa.5-6, ss.589-612, 2008 (SCI-Expanded, Scopus)

73. Synthesis and in vitro antimicrobial activity of new 2-[p-substituted-benzyl]-5-[substituted-carbonylamino]benzoxazoles

Tekiner-Gulbas B., ARPACI Ö., YILDIZ İ., Altanlar N.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , cilt.42, sa.10, ss.1293-1299, 2007 (SCI-Expanded, Scopus)

74. Vibrational spectroscopic studies and ab initio calculations of 5-methyl-2-(p-fluorophenyl)benzoxazole

Anto P. L., Panicker C. Y., Varghese H. T., Philip D., ARPACI Ö., Tekiner-Gulbas B., et al.

SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY , cilt.67, sa.3-4, ss.744-749, 2007 (SCI-Expanded, Scopus)

75. Synthesis and antimicrobial activity of some novel N-[2-substitutedbenzoxazol-5-yl]-2-[4-substituted- piperazin-1-yl]acetamides

Arisoy M., Temiz-Arpaci Ö., Kaynak-Onurdag F., YILDIZ İ., Aki-Sener E., Yalcin I., et al.

DRUGS OF THE FUTURE , cilt.32, ss.127-128, 2007 (SCI-Expanded)

76. Molecular modelling studies on some eukaruotic topoisomerase II enzyme inhibitor fused heterocyclic compounds

YILDIZ İ., Alper S., Ertan T., Temiz-Arpaci Ö., Tekiner-Gulbas B., Aki-Sener E., et al.

DRUGS OF THE FUTURE , cilt.32, ss.15-16, 2007 (SCI-Expanded)

77. Synthesis and biological evaluation of new N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamides and phenylacetamides as antimicrobial agents

Ertan T., YILDIZ İ., Ozkan S., ARPACI Ö., Kaynak F., Yalcin I., et al.

BIOORGANIC & MEDICINAL CHEMISTRY , cilt.15, sa.5, ss.2032-2044, 2007 (SCI-Expanded, Scopus)

78. QSAR of genotoxic active benzazoles

Tekiner-Gulbas B., ARPACI Ö., Oksuzoglu E., Eroglu H., YILDIZ İ., Diril N., et al.

SAR AND QSAR IN ENVIRONMENTAL RESEARCH , cilt.18, sa.3-4, ss.251-263, 2007 (SCI-Expanded)

79. A study on the genotoxic activities of some new benzoxazoles

Oksuzoglu E., ARPACI Ö., Tekiner-Gulbas B., Eroglu H., Sen G., Alper S., et al.

MEDICINAL CHEMISTRY RESEARCH , cilt.16, sa.1, ss.1-14, 2007 (SCI-Expanded, Scopus)

80. Synthesis, antimicrobial activity and QSARs of new benzoxazine-3-ones

Alper-Hayta S., Aki-Sener E., Tekiner-Gulbas B., YILDIZ İ., ARPACI Ö., Yalcin I., et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , cilt.41, sa.12, ss.1398-1404, 2006 (SCI-Expanded, Scopus)

81. 3D-QSAR study on heterocyclic topoisomerase II inhibitors using CoMSIA

Tekiner-Gulbas B., ARPACI Ö., YILDIZ İ., Aki-Sener E., Yalcin I.

SAR AND QSAR IN ENVIRONMENTAL RESEARCH , cilt.17, sa.2, ss.121-132, 2006 (SCI-Expanded)

82. A study on the antioxidant activities of some new benzazole derivatives

ARPACI Ö., Coban T., Tekiner-Gulbas B., Can-Eke B., YILDIZ İ., Aki-Sener E., et al.

ACTA BIOLOGICA HUNGARICA , cilt.57, sa.2, ss.201-209, 2006 (SCI-Expanded)

83. 3D-QSAR analysis on benzazole derivatives as eukaryotic topoisomerase II inhibitors by using comparative molecular field analysis method

ARPACI Ö., Tekiner-Gulbas B., YILDIZ İ., Aki-Sener E., Yalcin I.

BIOORGANIC & MEDICINAL CHEMISTRY , cilt.13, sa.23, ss.6354-6359, 2005 (SCI-Expanded, Scopus)

84. Investigating toxic effects of the HIV-RT inhibitor 2-phenoxymethyl-5- chloro-benzimidazole on rat liver

Uǧur Y., Akbay Yarpuzlu A., Nazikoǧlu A., Aşan E., YILDIZ İ., KELEŞ Ş.

Turkish Journal of Medical Sciences , cilt.35, sa.1, ss.5-12, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

85. Synthesis and antimicrobial activity of some 5-[2-(morpholin-4-yl)acetamido] and/or 5-[2-(4-substituted piperazin-1-yl)acetamido]2-(p-substituted phenyl)benzoxazoles

Temiz-Aripaci O., Ozdemir A., Yalcin I., YILDIZ İ., Aki-Sener E., Altanlar N.

ARCHIV DER PHARMAZIE , cilt.338, sa.2-3, ss.105-111, 2005 (SCI-Expanded, Scopus)

86. 3D-QSAR LEAD OPTIMIZATION ANALYSIS OF SOME NOVEL EUKARYOTIC TOPOISOMERASE II INHIBITORS

Yalcin I., Aki-Sener E., YILDIZ İ.

ANTICANCER RESEARCH , cilt.24, sa.5D, ss.3673, 2004 (SCI-Expanded)

87. Synthesis and antimicrobial activity of new 2-[p-substituted-benzyl]-5-[substituted-carbonyl-amino]benzoxazoles

Yildiz-Oren İ., Tekiner-Gulbas B., Yalcin I., ARPACI Ö., Aki-Sener E., Altanlar N.

ARCHIV DER PHARMAZIE , cilt.337, sa.7, ss.402-410, 2004 (SCI-Expanded, Scopus)

88. Quantitative structure-activity relationships using comparative molecular field analysis studies on 2-(p-substituted benzyl)-5-(substituted carbonylamino)benzoxazoles as antibacterial agents against Staphylococcus aureus

Yildiz-Oren İ., Tekiner-Gulbas B., ARPACI Ö., Yalcin I., Aki-Sener E.

ASIAN JOURNAL OF CHEMISTRY , cilt.16, sa.3-4, ss.1359-1366, 2004 (SCI-Expanded, Scopus)

89. A target site for template-based design of measles virus entry inhibitors

Plemper R., Erlandson K., Lakdawala A., Sun A., Prussia A., Boonsombat J., et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , cilt.101, sa.15, ss.5628-5633, 2004 (SCI-Expanded, Scopus)

90. Quantitative Structure-activity relationships using Comparative Molecular Field Analysis Studies on 2-(p-Substitutedbenzyl)-5-(substituted carbonylamino)benzoxazoles as Antibacterial Agents against Staphylococcus aureus

Yıldız İ., Tekiner Gülbaş P. B., Arpacı Ö., Yalçın İ., Akı-Şener E.

Asian Journal Of Chemistry , cilt.16, ss.1359-1366, 2004 (SCI-Expanded)

91. Some fused heterocyclic compounds as eukaryotic topoisomerase II inhibitors

Pinar A., Yurdakul P., YILDIZ İ., ARPACI Ö., Acan N., Aki-Sener E., et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS , cilt.317, sa.2, ss.670-674, 2004 (SCI-Expanded, Scopus)

92. Synthesis and structure-activity relationships of new antimicrobial active multisubstituted benzazole derivatives

Yildiz-Oren İ., Yalcin I., Aki-Sener E., Ucarturk N.

European Journal of Medicinal Chemistry , cilt.39, sa.3, ss.291-298, 2004 (SCI-Expanded, Scopus)

93. Synthesis and microbiological activity of some substituted N-(2-hydroxy-4-nitrophenyl) benzamides and phenylacetamides as possible metabolites of antimicrobial active benzoxazoles

Oren İ., Aki-Sener E., Ertas C., Arpaci Ö., Yalcin I., Altanlar N.

TURKISH JOURNAL OF CHEMISTRY , cilt.28, sa.4, ss.441-449, 2004 (SCI-Expanded, Scopus, TRDizin)

94. Synthesis and antimicrobial activity of some novel 2,6,7-trisubstituted-2H-3,4-dihydro-1,4-benzoxazin-3-one derivatives

Yalcin I., Tekiner B., Oren İ., Arpaci Ö., Aki-Sener E., Altanlar N.

INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY , cilt.42, sa.4, ss.905-909, 2003 (SCI-Expanded, Scopus)

95. DFT calculations of some antimicrobial active 3,4-dihydro-1,4-benzoxazin-3-one derivatives

YILDIZ İ., Tekiner-Gülbaş B. P.

Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.32, sa.3, ss.165-173, 2003 (Scopus)

96. Synthesis and HIV-1 reverse transcriptase inhibitor activity of some 2,5,6-substituted benzoxazole, benzimidazole, benzothiazole and oxazolo (4,5-b)pyridine derivatives

Akbay A., Oren İ., ARPACI Ö., Aki-Sener E., Yalcin I.

Arzneimittel-Forschung/Drug Research , cilt.53, sa.4, ss.266-271, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

97. The NH---FC dipole orientation effect for pendant exocyclic CH2F

Lankin D., Grunewald G., Romero F., Oren İ., Snyder J.

ORGANIC LETTERS , cilt.4, sa.21, ss.3557-3560, 2002 (SCI-Expanded, Scopus)

98. Synthesis and antimicrobial activity of some novel 2-(p-substituted-phenyl)-5-substituted-carbonylaminobenzoxazoles

Arpaci Ö., Oren İ., Altanlar N.

FARMACO , cilt.57, sa.3, ss.175-181, 2002 (SCI-Expanded)

99. QSAR s of some novel benzoxazole benzimidazole and oxazolo 4 5 b pyridine derivatives against C albicans

ÖREN İ., ARPACI Ö., YALÇIN İ., AKI YALÇIN E. E.

Ankara Üniversitesi Eczacılık Fakültesi Dergisi , cilt.31, sa.1, ss.21-32, 2002 (Hakemli Dergi)

100. QSAR s of some antibacterial active benzoxazoles against B subtilis

ARPACI Ö., YILDIZ İ., AKI YALÇIN E. E., YALÇIN İ., TEKİNER GÜLBAŞ P. B.

Ankara Üniversitesi Eczacilik Fakultesi Dergisi , cilt.31, sa.2, ss.73-82, 2002 (Hakemli Dergi)

101. Synthesis and microbiological activity of some N-(o-hydroxyphenyl)benzamides and phenylacetamides as the possible metabolites of antimicrobial active benzoxazoles: Part II

Sener E., Bingol K., Oren İ., Arpaci Ö., Yalcin I., Altanlar N.

FARMACO , cilt.55, sa.6-7, ss.469-476, 2000 (SCI-Expanded)

102. QSARs of some novel isosteric heterocyclics with antifungal activity

Yalcin I., Oren İ., Temiz Ö., Sener E.

Acta Biochimica Polonica , cilt.47, sa.2, ss.481-486, 2000 (SCI-Expanded, Scopus)

103. Oral Cerrahi Girisimlerde Intaranazal Midazolam Uygulanmasi

Mocan A., Filiz K., TUĞCU E. F., YILDIZ İ.

Ankara Üniversitesi Diş Hekimliği Fakültesi Dergisi , cilt.27, sa.3, ss.291-296, 2000 (Hakemli Dergi)

104. Synthesis and antimicrobial activity of some novel 2,5- and/or 6-substituted benzoxazole and benzimidazole derivatives

Oren İ., Temiz Ö., Yalcin I., Sener E., Altanlar N.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.7, sa.2, ss.153-160, 1999 (SCI-Expanded)

105. Synthesis and microbiological activity of some novel 5- or 6-methyl-2-(2,4-disubstituted phenyl)benzoxazole derivatives

Temiz Ö., Oren İ., Sener E., Yalcin I., Ucarturk N.

FARMACO , cilt.53, sa.5, ss.337-341, 1998 (SCI-Expanded, Scopus)

106. N-(2-hydroxy-5-chlorophenyl)thiophenylacetamide

Tarimci C., Ercan F., Kocoglu M., Oren İ.

ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS , cilt.54, ss.488-489, 1998 (SCI-Expanded, Scopus)

107. QSAR of some antifungal active benzoxazoles and benzimidazoles against C. albicans

YILDIZ İ.

Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.27, sa.1, ss.1-9, 1998 (Scopus)

108. Synthesis and microbiological activity of 5(or 6)-methyl-2-substituted benzoxazole and benzimidazole derivatives

Oren İ., Temiz Ö., Yalcin I., Sener E., Akin A., Ucarturk N.

Arzneimittel-Forschung/Drug Research , cilt.47, sa.12, ss.1393-1397, 1997 (SCI-Expanded, Scopus)

109. Synthesis and microbiological activity of some novel N-(2-hydroxyl-5- substitutedphenyl)benzacetamides, phenoxyacetamides and thiophenoxyacetamides as the possible metabolites of antimicrobial active benzoxazoles

Yalcin I., Kaymakcioglu B., Oren İ., Sener E., Temiz Ö., Akin A., et al.

Farmaco , cilt.52, sa.11, ss.685-689, 1997 (SCI-Expanded, Scopus)

110. Synthesis and structure-activity relationships of some 2,5- disubstituted benzoxazoles and benzimidazoles as antimicrobial agents

Sener E., Yalcin I., Temiz Ö., Oren İ., Akin A., Ucarturk N.

Farmaco , cilt.52, sa.2, ss.99-103, 1997 (SCI-Expanded, Scopus)

111. Synthesis Antibacterial Activity and QSAR s of some 5 Substituted 2 p Substitutedbenzyl benzoxazoles using the Free Wilson Analysis

AKI YALÇIN E. E., ARPACI Ö., ÖREN İ., YALÇIN İ., Akın A., Uçartürk N.

Ankara Üniversitesi Eczacılık Fakültesi Dergisi , cilt.24, sa.1, ss.10-20, 1995 (Scopus)

112. Structure-activity relationships of some antimicrobial 5-substituted 2-(3-pyridyl) benzoxazoles using quantum-chemical calculations

SENER E., TURGUT H., YALCIN I., OREN İ., TURKER L., CELEBI N., et al.

International Journal of Pharmaceutics , cilt.110, sa.2, ss.109-115, 1994 (SCI-Expanded, Scopus)

113. QSAR of Some Antibacterial Active Isosteric Heterocyclic Compounds against an Enterobacter

YALÇIN İ., AKI YALÇIN E. E., YILDIZ İ.

Trends in QSAR and Molecular Modelling 92 , ss.570-572, 1993 (Hakemli Dergi)

114. The synthesis and the structure-activity relationships of some substituted benzoxazoles, oxazolo(4,5-b)pyridines, benzothiazoles and benzimidazoles as antimicrobial agents

Yalçın İ., Ören İ., Şener E., Akin A., Uçartürk N.

European Journal of Medicinal Chemistry , cilt.27, sa.4, ss.401-406, 1992 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 120

1. Some New Benzoxazoles as Topoisomerase II Inhibitors2

YILDIZ İ., Karataş E., FOTO E., YALÇIN G., ZİLİFDAR FOTO F., ERTAN BOLELLİ T.

Uluslararası Katılımlı 5. İlaç Kimyası Kongresi, 30 Mart - 02 Nisan 2017, (Özet Bildiri)

2. Synthesis and molecular modeling studies of some novel benzothiazole derivatives as anti-cancer agents

YENİCE ÇAKMAK G., YILMAZ S., YILDIZ İ.

13th International symposium on pharmaceutical sciences, 22 Haziran 2021, (Özet Bildiri) Sürdürülebilir Kalkınma

3. Molecular Docking Analysis of New Antibacterial Lead Compounds for Staphylococcus aureus

YALÇIN G., acar c., YILDIZ İ.

Eurasian Congress on Molecular Biotechnology, 19 - 21 Eylül 2019, (Özet Bildiri)

4. Some New Oxazolo[4,5-b]pyridines as Topoisomerase IIα Inhibitors

YILDIZ İ., Karataş E., FOTO E., YALÇIN G., Ataei S., ERTAN BOLELLİ T., et al.

Uluslararası Katılımlı 7. İlaç Kimyası Kongresi, 14 - 17 Mart 2019, (Özet Bildiri)

5. Glycogen Synthase Kinase 3 Beta inhibition by several acetylcholinesterase inhibitors

YALÇIN G., DOĞRU B., YILDIZ İ.

4th International Turkic World Conferenceon Chemical Sciences and Technologies, Kiev, Ukrayna, 7 - 10 Eylül 2018, ss.145, (Özet Bildiri)

6. Molecular modeling studies on some aldose reductase enzyme inhibitors

BOLELLİ K., ERTAN BOLELLİ T., DOĞRU B., YILDIZ İ.

International Chemistry Biology Conference’18, Şarm El-Şeyh, Mısır, 11 - 14 Temmuz 2018, ss.159, (Özet Bildiri)

7. Investigation of Beta-secretase 1 Enzyme inhibition with known acetylcholinesterase inhibitors

YALÇIN G., YILDIZ İ.

4th International Turkic World Conferenceon Chemical Sciences and Technologies, Kiev, Ukrayna, 7 - 10 Eylül 2018, ss.146, (Özet Bildiri)

8. Docking studies of some sulfonamidobenzoxazole derivatives on aldose reductase enzyme2

ERTAN BOLELLİ T., BOLELLİ K., DOĞRU B., YILDIZ İ.

4th International Turkic World Conference on Chemical Sciences and Technologies, Kiev, 7 - 10 Eylül 2018, (Özet Bildiri)

9. Molecular Modelling Studies on Benzoxazines as Anticancer Agents

YILDIZ İ., YILMAZ S., Ataei S., ERTAN BOLELLİ T., BOLELLİ K., ZİLİFDAR F., et al.

International Chemistry Biology Conference’xx18, Şarm El_Şeyh, Mısır, 11 - 14 Temmuz 2018, ss.34, (Özet Bildiri)

10. Docking studies of some sulfonamidobenzoxazole derivatives on aldose reductase enzyme

ERTAN BOLELLİ T., BOLELLİ K., DOĞRU B., YILDIZ İ.

4th International Turkic World Conferenceon Chemical Sciences and Technologies, Kiev, Ukrayna, 7 - 10 Eylül 2018, ss.144, (Özet Bildiri)

11. Computational studies on glycogen synthase kinase 3 beta inhibitors

YALÇIN G., YILDIZ İ.

International Chemistry Biology Conference’18, Şarm El-Şeyh, Mısır, 11 - 14 Temmuz 2018, ss.153, (Özet Bildiri)

12. Some New Topoisomerase II Inhibitors

YILDIZ İ., Karataş E., FOTO E., YALÇIN G., Ataei S., ERTAN BOLELLİ T., et al.

4th International Turkic World Conferenceon Chemical Sciences and Technologies, Kiev, Ukrayna, 7 - 10 Eylül 2018, ss.127, (Özet Bildiri)

13. Molecular Binding Profile of Protoberberine Alkaloids on Receptor for Advanced GlycationEndproducts (RAGE) as a Drug Candidate for Alzheimer’s Diseases

DOĞRU B., YILDIZ İ., YALÇIN G.

International Chemistry and Biology Conference, Sharm El-Sheikh, Mısır, 11 - 14 Temmuz 2018, ss.154, (Özet Bildiri)

14. Synhesis of some new benzoxazoles as hTopo IIα Inhibitors

Karataş E., FOTO E., ZİLİFDAR F., YILDIZ İ.

12th International Symposium on Pharmaceutical Sciences, Ankara, Türkiye, 26 - 29 Haziran 2018, ss.373, (Özet Bildiri)

15. Molecular binding profile of protoberberine alkaloids onglycogen synthase kinase 3β as a drug candidatefor Alzheimer’s diseases

YALÇIN G., YILDIZ İ.

7th InternationalMolecular Biology and BiotechnologyCongress, Konya, Türkiye, 25 Nisan - 27 Eylül 2018, ss.42, (Özet Bildiri)

16. DprE1-Benzimidazole derivatives interactions using molecular modelling

YALÇIN G., Ersan R. H., ALGÜL Ö., YILDIZ İ.

Uluslar arası Katılımlı 6. İlaç Kimyası: İlaç Etkin Maddesi Tasarımı, Sentezi, Üretimi ve Standardizasyonu Kongresi, Antalya, Türkiye, 22 - 25 Mart 2018, ss.120, (Özet Bildiri)

17. Computational studies for drug design on beta-secretase 1 inhibition

YALÇIN G., YILDIZ İ.

Uluslar arası Katılımlı 6. İlaç Kimyası: İlaç Etkin Maddesi Tasarımı, Sentezi, Üretimi ve Standardizasyonu Kongresi, Antalya, Türkiye, 22 - 25 Mart 2018, ss.119, (Özet Bildiri)

18. Docking studies of 2-substituted-5-(4-trifluoromethylphenylsulfonamido)benzoxazole derivatives on human GST P1-1 enzyme

ERTAN BOLELLİ T., BOLELLİ K., Musdal Y., YILDIZ İ., AKI YALÇIN E. E., Mannervik B., et al.

The 69th Southeastern Regional Meeting of the American Chemical Society SERMACS 2017, 7 - 11 Kasım 2017, ss.95, (Özet Bildiri)

19. Development of new lead BACE1 enzyme inhibitors

YALÇIN G., YILDIZ İ.

5th International BAU Drug Design Congress, 19 - 21 Ekim 2017, ss.43, (Özet Bildiri)

20. Molecular modelling studies on glycogen synthase kinase 3B inhibitors for Alzheimer’xxs Diseases

YALÇIN G., YILDIZ İ.

2nd International Gazi Pharma Symposium, 11 - 13 Ekim 2017, ss.253, (Özet Bildiri)

21. Protoberberine alkoloids as a drug candidate for Alzheimer’xxs Diseases

YALÇIN G., YILDIZ İ.

2nd International Gazi Pharma Symposium, 11 - 13 Ekim 2017, ss.254, (Özet Bildiri)

22. Molecular Docking Studies of 2,5-Disubstituted Benzoxazole Derivatives as Aldose Reductase Enzyme Inhibitor

BOLELLİ K., ERTAN BOLELLİ T., DOĞRU B., YILDIZ İ.

3rd International Turkic World Conference on Chemical Sciences and Technologies, 10 - 13 Eylül 2017, ss.169, (Özet Bildiri)

23. Pharmacophore Generation Studies for Developing of Potential BACE1 Enzyme Inhibitors

YALÇIN G., YILDIZ İ.

3rd International Turkic World Conference on Chemical Sciences and Technologies, 10 - 13 Eylül 2017, ss.304, (Özet Bildiri)

24. Benzoxazine Derivatives as Antitumor Agents Targeting Topo I

YILDIZ İ., Ataei S., YILMAZ S., ERTAN BOLELLİ T., Foto E.

3rd International Turkic World Conference on Chemical Sciences and Technologies, 10 - 13 Eylül 2017, ss.55, (Özet Bildiri)

25. New nitro-benzoxazoles as antitumor agents targeting hTopo II

Karataş E., Foto E., YALÇIN G., ZİLİFDAR F., ERTAN BOLELLİ T., YILDIZ İ.

17th Hellenic Symposium on Medicinal Chemistry, 1 - 03 Haziran 2017, ss.23, (Özet Bildiri)

26. Molecular Docking Studies of Some Benzoxazine Derivatives as DNA Topoisomerase I Inhibitors

Ataei S., YILDIZ İ.

17th Hellenic Symposium on Medicinal Chemistry, 1 - 03 Haziran 2017, ss.68, (Özet Bildiri)

27. Molecular Docking Studies on Some Benzimidazole Derivatives as Possible Decaprenylphosphoryl-D-ribose oxidase Enzyme Inhibitors

YALÇIN G., Ersan R. H., YILDIZ İ., ALGÜL Ö.

Uluslararsı Katılımlı 5. İlaç Kimyası: İlaç Etkin Maddesi Tasarımı, Sentezi, Üretimi ve Standardizasyon Kongresi, 30 Mart - 02 Nisan 2017, ss.210, (Özet Bildiri)

28. Some Nwe Benzoxazole as Topoisomerase II inhibitors

YILDIZ İ., Karataş E., Foto E., YALÇIN G., ZİLİFDAR F., ERTAN BOLELLİ T.

Uluslararsı Katılımlı 5. İlaç Kimyası: İlaç Etkin Maddesi Tasarımı, Sentezi, Üretimi ve Standardizasyon Kongresi, 30 Mart - 02 Nisan 2017, ss.127, (Özet Bildiri)

29. Synthesis of 2,5-disubstitutedbenzoxazoles as hTopo I Inhibitors

Karataş E., Foto E., ZİLİFDAR F., YILDIZ İ.

24th Young Research Fellow Meeting, 8 - 10 Şubat 2017, (Özet Bildiri)

30. Molecular Docking Studies on SIRT1 Enzyme

ERTAN BOLELLİ T., BOLELLİ K., YILDIZ İ.

The Biology of Aging ”Advances in therapeutic approaches to extend healthspan”, 22 - 25 Ocak 2017, (Özet Bildiri)

31. Molecular modeling studies on benzoxazine derivatives as human Sirt3 inhibitors

Ataei S., YILDIZ İ.

The Biology of Aging ”Advances in therapeutic approaches to extend healthspan”, 22 - 25 Ocak 2017, (Özet Bildiri)

32. Anticancer effects on human leukemia HL 60 Cell line and molecular docking studies of novel 2 5 disubstitutedbenzoxazole derivatives

ÖKSÜZOĞLU E., ERTAN BOLELLİ T., Tarhan M., ÖZTÜRK K., YILDIZ İ.

6. Multidisipliner Kanser Araştırma Kongresi, 27 - 30 Ekim 2016, (Özet Bildiri)

33. SYNTHESIS MOLECULAR MODELLING OF SOME NEW BENZOXAZOLE DERIVATIVES AS TOPOISOMERASE II INHIBITORS

YILDIZ İ., Karataş E., Foto E., ZİLİFDAR F., Ataei S.

ICSD International Conference on Sustainable Development, 19 - 23 Ekim 2016, (Özet Bildiri)

34. CARBAMATE DERIVATIVES OF PYRIDAZINONE AS ACETYLCHOLINESTERASE INHIBITORS

Çiçekli Ş., DÜNDAR Y., ŞENOL F. S., ERDOĞAN ORHAN İ., YILDIZ İ., ÖNKOL T.

ICSD International Conference on Sustainable Development, 19 - 23 Ekim 2016, (Özet Bildiri)

35. Anticancer Effects on Human Leukemıa Hl 60 Cell Line And Molecular Docking Studies of Novel 2 5 Disubstituted Benzoxazole Derivatives

ÖKSÜZOĞLU E., ERTAN BOLELLİ T., Tarhan M., ÖZTÜRK K., YILDIZ İ.

MOKAD-2016, Konya, Türkiye, 27 - 30 Ekim 2016, ss.65, (Tam Metin Bildiri)

36. Investigation of Cytotoxic Genotoxic Epigenetic and Topoisomerase I Enzyme Inhibitory Effects of Benzoxazole Benzamide and Benzeneacetamide Derivatives

ZİLİFDAR F., Foto E., ERTAN BOLELLİ T., YALÇIN İ., AKI YALÇIN E. E., YILDIZ İ., et al.

International Conference On Biological Sciences (ICBS), Konya, Türkiye, 21 - 23 Ekim 2016, ss.133, (Özet Bildiri)

37. Antitumor Activities on Human Leukemia HL 60 Cell Line of Some Novel Sulfonamido Benzoxazoles

ÖKSÜZOĞLU E., ERTAN BOLELLİ T., Tarhan M., ÖZTÜRK K., YILDIZ İ.

4th International BAU Drug Design Congress, 13 - 15 Ekim 2016, (Özet Bildiri)

38. Molecular Docking Studies on Some Chalcone Derivatives as Possible Decaprenylphoshoryl D ribose oxidase DprE1 Enzyme Inhibitors

YALÇIN G., Göbek A., Aktaş Anıl D., BURMAOĞLU S., YILDIZ İ.

4th International BAU Drug Design Congress, 13 - 15 Ekim 2016, (Özet Bildiri)

39. In silico affinities of some statins to paraoxonase-1 enzyme

Duzgun Z., Kural B., ÖREM A., YILDIZ İ.

41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Türkiye, 3 - 08 Eylül 2016, cilt.283, ss.234, (Özet Bildiri)

40. Homology modeling and molecular docking study of the paraoxonase-1 and its polymorphic variants Q/R 192 and M/L 55 for non-statin lipid lowering drugs

Duzgun Z., KURAL B., ÖREM A., YILDIZ İ.

41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Türkiye, 3 - 08 Eylül 2016, cilt.283, ss.233, (Özet Bildiri)

41. Molecular binding profile of protoberberine alkoloids on amyloid precursor protein-cleaving enzyme 1 (BACE1) as a drug candidate for Alzheimer's diseases

YALÇIN ÖZKAT G., YILDIZ İ.

41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Türkiye, 3 - 08 Eylül 2016, cilt.283, ss.232, (Özet Bildiri)

42. Synthesis and DNA topoisomerases I inhibitor activity of some novel benzoxazine derivatives

Ataei S., Foto E., YILDIZ İ.

15th Belgian Organic Synthesis Symposium BOSS XV, 10 - 15 Temmuz 2016, (Özet Bildiri)

43. Theoretical investigations on the molecular structure vibrational spectra HOMO LUMO and NBO analysis of 5 chloro 2 4 chlorophenoxy methyl benzimidazole

Mary Y. S., Jojo P., Panicker C. Y., Alsenoy C. V., Ataei S., YILDIZ İ.

Third International Conference on New Trends in Chemometrics and Applications, 25 - 28 Mayıs 2016, (Özet Bildiri)

44. Design and synthesis of novel sulfonamide containing benzoxazoles as human GST P1 1 inhibitors

ERTAN BOLELLİ T., Musdal Y., Mannervick B., BOLELLİ K., YILMAZ S., ÖZTÜRK Ö., et al.

Royal Society of Chemistry, Challenges in Organic Chemistry, 20 - 23 Mart 2016, (Özet Bildiri)

45. Synthesis of some new benzoxazoles as DNA Topoisomerase I Inhibitors

Karataş E., Foto E., ZİLİFDAR F., YILDIZ İ.

4. İlaç Kimyası: İlaç Etkin Maddesi Tasarımı, Sentezi, Üretimi ve Standardizasyonu Kongresi, Türkiye, 17 - 20 Mart 2016, (Özet Bildiri)

46. Predicting ADME Tox Properties of Some Topoisomerase I

Ataei S., YILDIZ İ.

4. İlaç Kimyası: İlaç Etkin Maddesi Tasarımı, Sentezi, Üretimi ve Standardizasyonu Kongresi, Türkiye, 17 - 20 Mart 2016, (Özet Bildiri)

47. Determination of some Macrolide Antibiotics by High Liquid Performance Chromatographic Method HPLC

Ataei S., YILDIZ İ., Karban Ö., Karabulut M., Şimşek H., Tahiyeu R., et al.

4. İlaç Kimyası: İlaç Etkin Maddesi Tasarımı, Sentezi, Üretimi ve Standardizasyonu Kongresi, Türkiye, 17 - 20 Mart 2016, (Özet Bildiri)

48. Pharmacophore Generation Studies For The Discovery OfPotential Acetylcholinesterase Inhibitors

YALÇIN G., Ataei S., YILDIZ İ.

3rd International BAU Drug Design Congress2015, 1 - 03 Ekim 2015

49. Molecular Modeling Studies Topoisomerase I Inhibitors

YILDIZ İ., ERTAN BOLELLİ T., ATAEİ S., YILMAZ S., FOTO E., DİRİL N., et al.

3rd International BAU-Drug Design Symposium 2015, İstanbul, Türkiye, 1 - 03 Ekim 2015, ss.47-48, (Özet Bildiri)

50. Molecular Modeling Studıes Topoisomerase IInhibitors

YILDIZ İ., BOLELLİ T., Ataei S., YILMAZ S., Foto E., YALÇIN İ.

3rd International BAU Drug Design Congress 2015, 1 - 03 Ekim 2015, (Özet Bildiri)

51. In silico prediction ADME Tox properties of some topoisomerase I inhibitors

Karataş E., Ataei S., YILDIZ İ.

8th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2015), Chios, Greece, PO1-11, p64, 21 - 25 Haziran 2015

52. Pharmacophore analysis and molecular docking studies on benzoxazines as topoisomerase I inhibitors

YILDIZ İ., Sanaz A., YILMAZ S., BOLELLİ T., Foto E., YALÇIN İ.

8th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources Chios, Greece, OC-22, p46, 21 - 25 Haziran 2015, (Özet Bildiri)

53. Molecular Studies on Benzazole Derivatives as HIV 1 Reverse Transcriptase Inhibitors

ATAEİ S., BAYRAK Y., YILMAZ S., ERTAN BOLELLİ T., YILDIZ İ.

8th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2015), CHIOS, Yunanistan, 21 - 25 Haziran 2015, ss.70, (Özet Bildiri) Sürdürülebilir Kalkınma

54. Molecular studies on benzazole derivtives as HIV 1 Reverse transcriptase inhibitors

Ataei S., Bayrak Y., YILMAZ S., BOLELLİ T., YILDIZ İ.

8th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2015), Chios, Greece, PO2-17, p70, 21 - 25 Haziran 2015 Sürdürülebilir Kalkınma

55. Evaluation of in vitro genotoxic potentials of 4 methyl 6 substituted 2H 3 4 dihydro 1 4 benzoxazin 3 one derivatives on HeLa cells

Foto E., ZİLİFDAR F., YILMAZ S., DİRİL N., YALÇIN İ., YILDIZ İ., et al.

11th International Symposium on Pharmaceutical Sciences (ISOPS 11th), June 09-12, 2015, 9 - 12 Haziran 2015

56. QSAR 1 İlkeler

YILDIZ İ.

Bilgisayar Destekli İlaç Tasarımı Kursu, Biruni Üniversitesi Eczacılık Fakültesi, Türkiye, 11 - 12 Mayıs 2015

57. MOLECULAR DOCKING AND PHARMACOPHORE ANALYSIS ON SOME TOPOISOMERASE I TARGETTED ANTITUMOR BENZOXAZOLE AND ANALOGUES

YILDIZ İ., BOLELLİ T., Ataei S., YILMAZ S., Karataş E., BOLELLİ K., et al.

GTC European Pharma 2015 9th Drug Design and Medicinal Chemistry Conference, 5 - 08 Mayıs 2015

58. Molecular Modeling Studies on BS10 as Topoisomerase I Poison

YILDIZ İ., Ataei S., YILMAZ S., BOLELLİ T., Foto E.

1st International Congress: from drug discovery to drug delivery, Royal Olympic Hotel, Athens, Greece, 13 - 15 Kasım 2014, (Özet Bildiri)

59. Computer Aided Molecular Modeling of the Binding Site and GSH Conjugation Features of the New Human GST P1 1 Inhibitors

YALÇIN İ., ERTAN BOLELLİ T., Musdal Y., BOLELLİ K., YILMAZ S., AKSOY Y., et al.

The 3rd International Conference on Computation for Science and Technology, Balvi, Letonya, 23 - 25 Eylül 2014, ss.6, (Özet Bildiri)

60. Anticancer Drug Design Studies using Molecular Modeling Techniques

AKI YALÇIN E. E., ERTAN BOLELLİ T., BOLELLİ K., YILMAZ S., ÖZTÜRK Ö., TAŞKIN TOK T., et al.

The 3rd International Conference on Computation for Science and Technology, Balvi, Letonya, 23 - 25 Eylül 2014, ss.10, (Özet Bildiri)

61. Pharmacophore Identification Analysis on hGST P1 1 Enzyme Inhibitory Active Benzazole Derivatives

BOLELLİ K., YALÇIN İ., ERTAN BOLELLİ T., YILMAZ S., ÖZTÜRK Ö., YILDIZ İ., et al.

The 3rd International Conference on Computation for Science and Technology, Balvi, Letonya, 23 - 25 Eylül 2014, ss.76, (Özet Bildiri)

62. Molecular Docking Studies on Human Glutathione S transferase Enzyme hGSTP1 1

ERTAN BOLELLİ T., YALÇIN İ., Musdal Y., YILMAZ S., BOLELLİ K., ÖZTÜRK Ö., et al.

The 3rd International Conference on Computation for Science and Technology, Balvi, Letonya, 23 - 25 Eylül 2014, ss.28, (Özet Bildiri)

63. Computational Drug Design Studies for Multidrug Resistance AcrAB TolC Efflux Pump Inhibitors on Escherichia coli

YILMAZ S., ERTAN BOLELLİ T., BOLELLİ K., ÖZTÜRK Ö., Ataei S., YILDIZ İ., et al.

The 3rd International Conference on Computation for Science and Technology, Balvi, Letonya, 23 - 25 Eylül 2014, ss.62, (Özet Bildiri)

64. Molecular Docking Studies of AcrB Trimeric Multidrug Efflux Pumps

YILMAZ S., ERTAN BOLELLİ T., BOLELLİ K., ÖZTÜRK Ö., ATAEİ S., YILDIZ İ., et al.

20th European Symposium on Quantitative Structure-Activity Relationships (20th EuroQSAR), St-Petersburg, Rusya, 31 Ağustos - 04 Eylül 2014, ss.170, (Özet Bildiri)

65. Molecular Modeling Studies on Some Benzazole Derivatives as Topoisomerase I Poison

YILDIZ İ., ERTAN BOLELLİ T., YILMAZ S., ATAEİ S., BOLELLİ K., ÖZTÜRK Ö., et al.

20th European Symposium on Quantitative Structure-Activity Relationships (20th EuroQSAR), St-Petersburg, Rusya, 31 Ağustos - 04 Eylül 2014, ss.221, (Özet Bildiri)

66. Description of the Binding Site and GSH Conjugation Features of the New Human GST P1 1 Inhibitors

YALÇIN İ., ERTAN BOLELLİ T., MUSDAL Y., BOLELLİ K., YILMAZ S., AKSOY Y., et al.

20th European Symposium on Quantitative Structure-Activity Relationships (20th EuroQSAR), St-Petersburg, Rusya, 31 Ağustos - 04 Eylül 2014, ss.224, (Özet Bildiri)

67. Identification of Mechanism of Action of DNA Topoisomerase II Inhibitors by Molecular Modeling Studies

AKI YALÇIN E. E., ERTAN BOLELLİ T., TAŞKIN TOK T., ÖZEN Ç., BOLELLİ K., YILMAZ S., et al.

20th European Symposium on Quantitative Structure-Activity Relationships (20th EuroQSAR), St Petersburg, Rusya, 31 Ağustos - 04 Eylül 2014, ss.52, (Özet Bildiri)

68. Common Feature Pharmacophore Generation of Neurokinin 1 Receptor Antagonists

ÖZTÜRK Ö., AKI YALÇIN E. E., ERTAN BOLELLİ T., BOLELLİ K., YILMAZ S., YILDIZ İ., et al.

The 3rd International Conference on Computation for Science and Technology, Balvi, Letonya, 23 - 25 Eylül 2014, ss.103, (Özet Bildiri)

69. Molecular Modeling Studies on DNA Topoisomerase II Inhibitors

AKI YALÇIN E. E., ERTAN BOLELLİ T., TAŞKIN TOK T., YILMAZ S., BOLELLİ K., ÖZTÜRK Ö., et al.

2nd International BAU-Drug Design Symposium 2014, İstanbul, Türkiye, 17 - 19 Nisan 2014, ss.18, (Özet Bildiri)

70. Description of the Binding Site Features of Some Fused Heterocycles as New Human GST P1 1 Inhibitors

YALÇIN İ., ERTAN BOLELLİ T., Musdal Y., BOLELLİ K., YILMAZ S., AKSOY Y., et al.

2nd International BAU-Drug Design Symposium 2014, İstanbul, Türkiye, 17 - 19 Nisan 2014, ss.9, (Özet Bildiri)

71. Molecular Modeling Studies On Some Topoisomerase I Inhibitors

YILDIZ İ., Ataei S., YILMAZ S., ERTAN BOLELLİ T., Foto E., AKI YALÇIN E. E., et al.

2nd International BAU-Drug Design Symposium 2014, İstanbul, Türkiye, 17 - 19 Nisan 2014, ss.38, (Özet Bildiri)

72. Vibrational Spectroscopic Studies and DFT Calculations of 4 Fluoro N 2 Hydroxy 4 Nitrophenyl Benzamide

USHAKUMARI L., VARGHESE H. T., PANICKER C. Y., ERTAN BOLELLİ T., YILDIZ İ.

2nd International Conference on New Trends in Chemometrics and Applications (NTCA-2013), Ankara, Türkiye, 25 - 28 Ekim 2013, ss.56, (Özet Bildiri)